DIVERGENE LLC
Website: Company Website
Address: 1304 Fairmont St, Durham, North Carolina, 27713-8979
Phone: (979) 209-0188
Contact Person: KAM TO
Legal Structure: LLC
Year Established: 2021
Business Type: Research and Development (10 %), Service (90 %)
Principals: 1. Kam To, President and CEO
Ownership: Asian Pacific American, Other Minority Owned, Self-Certified Small Disadvantaged Business
Products & Services
Divergene is a provider of genomics services through Software-as-a-Service, catering to both government and commercial institutions. Our services are based on high-throughput next-generation sequencing (NGS) technology, which enables the computation and analysis of genomic and other omics data including single-cell transcriptomics. With years of experience and published scientific research, coupled with machine learning and data science, we deliver results through user-friendly visualizations and dashboards. Divergene provides actionable insights to support precision medicine, gene/cell therapy, and gene editing in research and characterization. At Divergene, we are constantly striving to provide the best possible service for our clients. We are always expanding our capabilities and improving our processes so that we can provide the best possible results.
Keywords
- Bioinformatics
- Biostatistics
- Computing
- Genomics
- Analysis
- Next Generation Sequencing
- Ngs
- Illumina
- Pacbio
- Nanopore
- Computational Biology
- Rna-seq
- Atac-seq
- Single Cell
- Whole Genome Sequencing
- Data Analysis
- Gene Expression
- Single-cell Genomics
- Crispr
- Gene Editing
- Cas
- Spatial
- Transcriptomic
- Sequencing
- Machine Learning
NAICS Code(s)
- 518210: Data Processing, Hosting, and Related Services
- 541511: Custom Computer Programming Services
- 541512: Computer Systems Design Services
- 541519: Other Computer Related Services
- 541690: Other Scientific and Technical Consulting Services
Contract History
Name: Leidos Biomedical Research Inc.
Contract: HHSN261201500003I
Start: 10/01/2022
End: 12/01/2022
Value: $17,000
Contact: Brian Bowser
Phone:
Name: Frederick National Laboratory for Cancer Research
Contract: 75N91019D00024
Start: 04/01/2022
End: 05/30/2022
Value: $9,000
Contact: Patty Green
Phone:
If you notice any discrepancies in your company profile, or wish to request updates or removals, please contact us to ensure your information is accurate and up-to-date.